Opelz G, Terasaki P I
N Engl J Med. 1978 Aug 24;299(8):369-74. doi: 10.1056/NEJM197808242990801.
We examined whether rejection of a previous graft rendered a recipient immunized against subsequent kidney transplants in over 1900 retransplants. The one-year survival rate (43 +/- 1 per cent [ +/- S.E.M.]) of second grafts from cadaver donors was only slightly (but statistically significantly) lower than that of first transplant (47 +/- 1 per cent, P less than 0.02). Repeated HLA mismatches in 180 second transplants did not show a lower survival rate than 925 grafts with no repeated HLA incompatibility. We conclude that the danger of immunization by previous grafts has been overemphasized from studies in laboratory animals. Those who rejected the first graft rapidly (high responders) had significantly shorter survival of the second graft compared with those who rejected the initial graft slowly (low responders) (60 +/- 3 versus 31 +/- 3 per cent at one year, P less than 0.00001).
我们在1900多例再次移植中研究了既往移植肾的排斥反应是否会使受者对后续肾移植产生免疫。尸体供者第二次移植肾的一年生存率(43±1%[±标准误])仅略低于(但具有统计学显著性)首次移植(47±1%,P<0.02)。180例第二次移植中重复出现的HLA错配与925例无重复HLA不相容的移植相比,生存率并未降低。我们得出结论,既往移植导致免疫的危险在实验室动物研究中被过度强调了。与那些缓慢排斥初次移植肾的受者(低反应者)相比,那些迅速排斥初次移植肾的受者(高反应者)第二次移植肾的存活时间明显更短(一年时分别为60±3%和31±3%,P<0.00001)。